MSI Financial Services’s Acorda Therapeutics ACOR Stock Holding History

MSI Financial Services’s Portfolio ACOR Stock Details ACOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Hold	0	–	–	–	4061
2016 Q3	–	Hold	0	–	–	–	4081
2016 Q2	–	Hold	0	–	–	–	3796
2016 Q1	–	Hold	0	–	–	–	3821
2015 Q4	–	Hold	0	–	–	–	3719
2015 Q2	–	Sell	-4	Closed	-$17K	–	3298
2015 Q1	$17K	Buy	4 +2	+100%	+$9.16K	﹤0.01%	1901
2014 Q4	$10K	Hold	2	–	–	﹤0.01%	1842
2014 Q3	$8K	Hold	2	–	–	﹤0.01%	1935
2014 Q2	$8K	Hold	2	–	–	﹤0.01%	1906
2014 Q1	$9K	Buy	+2	New	+$8.09K	﹤0.01%	1807

Other funds holding ACOR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

MSI Financial Services's ACOR Position: Q4 2016 in Review

MSI Financial Services held its Acorda Therapeutics (ACOR) position steady in Q4 2016 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #4061.

MSI Financial Services first reported a position in ACOR in Q1 2014 and has held it in 5 quarters since. The position peaked at $17K in Q1 2015. 175 funds tracked by Wall St. Rank hold ACOR as of Q4 2016.

MSI Financial Services held 0 shares of Acorda Therapeutics worth $0 as of Q4 2016.
MSI Financial Services left its Acorda Therapeutics share count unchanged in Q4 2016.
Acorda Therapeutics made up ﹤0.01% of MSI Financial Services's portfolio in Q4 2016, its #4061 holding.
MSI Financial Services first reported a position in Acorda Therapeutics in Q1 2014 and has held it in 5 quarters since.
MSI Financial Services's Acorda Therapeutics position peaked at $17K in Q1 2015.
175 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q4 2016.

Based on MSI Financial Services's 13F filing for Q4 2016, filed 13 Jan 2017.